These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 21338318)

  • 1. Clinical significance of tumor protein D52 immunostaining in a large series of Ewing's sarcoma family of tumors.
    Machado I; López-Guerrero JA; Calabuig-Fariñas S; Hardy JR; Scotlandi K; Picci P; Byrne JA; Llombart-Bosch A
    Pediatr Dev Pathol; 2011; 14(3):255-6. PubMed ID: 21338318
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
    Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
    Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
    J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
    Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
    Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
    Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
    Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour.
    Kang GH; Kim KM; Park CK; Kang DY
    Histopathology; 2009 Sep; 55(3):368-9. PubMed ID: 19723158
    [No Abstract]   [Full Text] [Related]  

  • 9. Intramyofiber skeletal muscle invasion in Ewing's sarcoma of bone: clinicopathologic observations from the intergroup Ewing's sarcoma study.
    Stratton B; Askin FB; Kissane JM
    Am J Pediatr Hematol Oncol; 1982; 4(2):231-5. PubMed ID: 7114406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of P53 status in Ewing sarcoma.
    de Alava E; Antonescu CR; Panizo A; Leung D; Meyers PA; Huvos AG; Pardo-Mindán FJ; Healey JH; Ladanyi M
    Cancer; 2000 Aug; 89(4):783-92. PubMed ID: 10951341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing's sarcoma: value of tumor necrosis as a predictive factor.
    de Stéfani E; Carzoglio J; Deneo Pellegrini H; Olivera L; Cendan M; Kasdorf H
    Bull Cancer; 1984; 71(1):16-21. PubMed ID: 6713111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
    Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
    Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
    Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
    Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytologic and cytochemical characteristics of Ewing's tumor and reticulosarcoma of the bone].
    Esiutina OS
    Lab Delo; 1972; 4():218-21. PubMed ID: 4119842
    [No Abstract]   [Full Text] [Related]  

  • 16. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
    Schmidt D; Harms D
    Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines.
    Schlauder SM; Steffensen TS; Morgan M; Letson DG; Pledger WJ; Ma L; Bui MM
    Fetal Pediatr Pathol; 2008; 27(2):83-97. PubMed ID: 18568996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
    Lee JA; Kim DH; Cho J; Lim JS; Koh JS; Yoo JY; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2011 Jun; 41(6):776-82. PubMed ID: 21415003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological markers of diagnostic value in Ewing's sarcoma: the use of antibodies against the antigen p30/32 MIC2, called 013].
    Ladenheim H; García A; Avagnina A; Porta J; Elsner B
    Medicina (B Aires); 1995; 55(2):184-6. PubMed ID: 7565061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.